Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients

References

• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• VijayanVKChronic obstructive pulmonary diseaseIndian J Med Res2013137225126923563369
   PubMed Web of Science ®Google Scholar
• WangZLEvolving role of systemic inflammation in comorbidities of chronic obstructive pulmonary diseaseChin Med J (Engl)2010123233467347822166533
   PubMed Web of Science ®Google Scholar
• MacNeeWSystemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary diseaseAnn Med201345329130023110517
   PubMed Web of Science ®Google Scholar
• AoshibaKYokohoriNNagaiAAlveolar wall apoptosis causes lung destruction and emphysematous changesAm J Respir Cell Mol Biol200328555556212707011
   PubMed Web of Science ®Google Scholar
• MoudedMEgeaEEBrownMJEpithelial cell apoptosis causes acute lung injury masquerading as emphysemaAm J Respir Cell Mol Biol200941440741419188661
   PubMed Web of Science ®Google Scholar
• DemedtsIKDemoorTBrackeKRJoosGFBrusselleGGRole of apoptosis in the pathogenesis of COPD and pulmonary emphysemaRespir Res2006715316571143
   PubMed Web of Science ®Google Scholar
• ParkJWRyterSWChoiAMFunctional significance of apoptosis in chronic obstructive pulmonary diseaseCOPD20074434735318027162
   PubMedGoogle Scholar
• RobertsonNMRosemillerMLindemeyerRGSteplewskiAZangrilliJGLitwackGTRAIL in the airwaysVitam Horm2004672014916715110176
   PubMed Web of Science ®Google Scholar
• KayagakiNYamaguchiNNakayamaMExpression and function of TNF-related apoptosis-inducing ligand on murine activated NK cellsJ Immunol199916341906191310438925
   PubMed Web of Science ®Google Scholar
• WeckmannMCollisonASimpsonJLCritical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway diseaseNat Med200713111308131517934471
   PubMed Web of Science ®Google Scholar
• AlmasanAAshkenaziAApo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapyCytokine Growth Factor Rev2003143–433734812787570
   PubMed Web of Science ®Google Scholar
• DaigleISimonHUAlternative functions for TRAIL receptors in eosinophils and neutrophilsSwiss Med Wkly200113117–1823123711420819
   PubMed Web of Science ®Google Scholar
• SchneiderPThomeMBurnsKTRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaBImmunity1997768318369430228
   PubMed Web of Science ®Google Scholar
• KischkelFCLawrenceDAChuntharapaiASchowPKimKJAshkenaziAApo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5Immunity200012661162010894161
   PubMed Web of Science ®Google Scholar
• TrunehASharmaSSilvermanCTemperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptorJ Biol Chem200027530233192332510770955
   PubMed Web of Science ®Google Scholar
• JohnstoneRWFrewAJSmythMJThe TRAIL apoptotic pathway in cancer onset, progression and therapyNat Rev Cancer200881078279818813321
   PubMed Web of Science ®Google Scholar
• BilskiAPasz-WalczakGKubiakRTRAIL protein expression in breast cancer cells correlates with nuclear gradeArch Med Sci20106454555122371798
   PubMed Web of Science ®Google Scholar
• YildizYYaylim-EraltanIArikanSErgenHAKucucukSIsbirTIs there any correlation between TNF-related apoptosis-inducing ligand (TRAIL) genetic variants and breast cancer?Arch Med Sci20106693293622427769
   PubMed Web of Science ®Google Scholar
• McGrathEEMarriottHMLawrieATNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammationJ Leukoc Biol201190585586521562052
   PubMed Web of Science ®Google Scholar
• BemRABosAPWosten-van AsperenRMPotential role of soluble TRAIL in epithelial injury in children with severe RSV infectionAm J Respir Cell Mol Biol201042669770519635930
   PubMed Web of Science ®Google Scholar
• CollisonAFosterPSMattesJEmerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responsesClin Exp Pharmacol Physiol200936111049105319656161
   PubMed Web of Science ®Google Scholar
• TisatoVGarrovoCBiffiSIntranasal administration of recombinant TRAIL down-regulates CXCL-1/KC in an ovalbumin-induced airway inflammation murine modelPLoS One2014912e11538725506835
   PubMed Web of Science ®Google Scholar
• AkramKMLomasNJForsythNRSpiteriMAAlveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53Int J Clin Exp Pathol20147255256424551275
   PubMed Web of Science ®Google Scholar
• HameedAGArnoldNDChamberlainJInhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertensionJ Exp Med2012209111919193523071256
   PubMed Web of Science ®Google Scholar
• MorissetteMCParentJMilotJAlveolar epithelial and endothelial cell apoptosis in emphysema: what we know and what we need to knowInt J COPD200941931
   Google Scholar
• MorissetteMCVachon-BeaudoinGParentJChakirJMilotJIncreased p53 level, Bax/Bcl-x(L) ratio, and TRAIL receptor expression in human emphysemaAm J Respir Crit Care Med2008178324024718511705
   PubMed Web of Science ®Google Scholar
• MorissetteMCParentJMilotJThe emphysematous lung is abnormally sensitive to TRAIL-mediated apoptosisRespir Res20111210521824395
   PubMed Web of Science ®Google Scholar
• GantenTMSykoraJKoschnyRPrognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancerJ Mol Med (Berl)20098710995100719680616
   PubMed Web of Science ®Google Scholar
• ToiyamaDTakahaNShinnohMSignificance of serum tumor necrosis factor-related apoptosis-inducing ligand as a prognostic biomarker for renal cell carcinomaMol Clin Oncol201311697424649125
   PubMedGoogle Scholar
• BisginAKargiAYalcinADIncreased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancerBMC Cancer2012125822313795
   PubMed Web of Science ®Google Scholar
• YalcinADBisginAKargiAGorczynskiRMAkdisCASerum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatmentMed Sci Monit20121831115
   Web of Science ®Google Scholar
• YalcinADBisginASoluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitisMed Sci Monit20121810617621
   Web of Science ®Google Scholar
• AzabNARadyHMMarzoukSAElevated serum TRAIL levels in scleroderma patients and its possible association with pulmonary involvementClin Rheumatol20123191359136422729471
   PubMed Web of Science ®Google Scholar
• DuJWangLHanJGaoLMaCLiangXSerum soluble death receptor 5 concentration in patients with chronic hepatitis B is associated with liver damage and viral antigen levelClin Biochem20124510–1184584722537456
   PubMed Web of Science ®Google Scholar
• KavurmaMMSchoppetMBobryshevYVKhachigianLMBennettMRTRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-kappaB and induction of insulin-like growth factor-1 receptorJ Biol Chem2008283127754776218178561
   PubMed Web of Science ®Google Scholar
• SecchieroPZerbinatiCRimondiETRAIL promotes the survival, migration and proliferation of vascular smooth muscle cellsCell Mol Life Sci200461151965197415289937
   PubMed Web of Science ®Google Scholar
• StaggHWBowenKASawantDARodriguezMTharakanBChildsEWTumor necrosis factor-related apoptosis-inducing ligand promotes microvascular endothelial cell hyperpermeability through phosphatidylinositol 3-kinase pathwayAm J Surg2013205441942523375756
   PubMed Web of Science ®Google Scholar
• Degli-EspostiMTo die or not to die – the quest of the TRAIL receptorsJ Leukoc Biol199965553554210331480
   PubMed Web of Science ®Google Scholar
• LiuJQuXXuLPhosphoinositide 3-kinase/Akt and nuclear factor kappaB pathways are involved in tumor necrosis factor-related apoptosis-inducing ligand resistance in human gastric cancer cellsMol Med Rep20103349149621472268
   PubMed Web of Science ®Google Scholar
• HigashimotoYIwataTOkadaMSatohHFukudaKTohdaYSerum biomarkers as predictors of lung function decline in chronic obstructive pulmonary diseaseRespir Med200910381231123819249197
   PubMed Web of Science ®Google Scholar
• TanniSEPelegrinoNRAngeleliAYCorreaCGodoyISmoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patientsJ Inflamm (Lond)201072920534161
   PubMed Web of Science ®Google Scholar
• KaradagFKirdarSKarulABCeylanEThe value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary diseaseEur J Intern Med200819210410818249305
   PubMed Web of Science ®Google Scholar
• ChiangCHChuangCHLiuSLTransforming growth factor-beta1 and tumor necrosis factor-alpha are associated with clinical severity and airflow limitation of COPD in an additive mannerLung201419219510224153451
   PubMed Web of Science ®Google Scholar
• Pinto-PlataVMMullerovaHTosoJFC-reactive protein in patients with COPD, control smokers and non-smokersThorax2006611232816143583
   PubMed Web of Science ®Google Scholar